Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany sees rise in equipment spending:

This article was originally published in Clinica

Executive Summary

In 2001, German health service expenditure on medical equipment, including bandages, pharmaceuticals and dentures, for the first time outstripped expenditure on medical services, says a report published last week by the federal statistical office. Of the total healthcare expenditure of E225bn ($248bn) in 2001, medical equipment funding amounted to some E60.4bn (26.7%), marginally ahead of the E59.6bn spent on physicians costs (26.4%) and the E51.6bn spent on nursing costs (22.8%). Between 1992 and 2001, expenditure rose by 14.8% after inflation, to 10.9% of GDP, placing it third in the world in terms of healthcare spending. In 2001, per capita expenditure on healthcare was E2,740. At this point some 4.1 million people, or every tenth employee in Germany, worked for the health service, although only 2.7 million were employed as full-time staff.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061947

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel